DR. MALOBA WEKESA

The increasing availability of HIV clinics providing highly active antiretroviral therapy (HAART) has dramatically reduced AIDS-related morbidity and mortality in resource-limited settings. However, the impact of HAART on development and progression of cervical neoplasia and invasive cervical cancer remains uncertain [ The following popper user interface control may not be accessible. Tab to the next button to revert the control to an accessible version. Destroy user interface control1]. The longer life expectancy among HIV-infected women receiving HAART may actually increase the overall risk for cervical cancer, underscoring the need for prevention strategies for this high-risk population. A potentially cost-effective way of providing this “primary” care may be through HIV clinics, which are generally well staffed and have more resources than government or private clinics [ The following popper user interface control may not be accessible. Tab to the next button to revert the control to an accessible version. Destroy user interface control2]. In addition to utilizing the staffing and infrastructure in place to provide HIV care and HAART, incorporating cervical cancer screening into an HIV clinic visit may increase screening uptake and follow up. One key element of cervical cancer prevention is the coupling of accurate screening methodologies with safe and effective outpatient treatment for cervical neoplasia. The loop electrosurgical excision procedure (LEEP) has better efficacy among HIV-infected women than cryotherapy [ The following popper user interface control may not be accessible. Tab to the next button to revert the control to an accessible version. Destroy user interface control3], and although LEEP requires electricity, it has been used successfully in resource-limited settings [ The following popper user interface control may not be accessible. Tab to the next button to revert the control to an accessible version. Destroy user interface control4]. However, LEEP is generally considered a surgical procedure to be performed by physicians or highly-trained midwives. We sought to establish the feasibility and safety of training midlevel HIV primary care providers to perform LEEP in an HIV care and treatment clinic in Kisumu, Kenya. Ethical approval was obtained from all collaborating institutions prior to initiation of screening and treatment. This evaluation took place at the Family AIDS Care and Education Services (FACES) clinic in Kisumu, Kenya. Kisumu, Kenya’s third largest city, has a population of 400 000. FACES partners with the Kenyan Government to provide free HIV care services as per Ministry of Health guidelines. Most visits are done by clinical officers (physician assistants), with medical officers available for consultation. As part of the cervical cancer screening program, all interested clinical officers at FACES were offered LEEP training. Between October 2007 and October 2009, 4 clinical officers underwent training and certification, and performed 181 LEEPs. Women were followed up for complications by telephone at 1 week and during a return visit at 1 month. All women were seen within 6 weeks of LEEP. Five women (3%) had procedure-related complications (Table 1). With the exception of the antibiotics, no additional treatment or referral was required. In our experience, LEEP was performed safely by clinical officers within an HIV-care clinic, expanding potential options for cervical cancer screening programs.